Suppr超能文献

开发免疫治疗肿瘤反应的通用语言:使用一维测量的免疫相关反应标准。

Developing a common language for tumor response to immunotherapy: immune-related response criteria using unidimensional measurements.

机构信息

Department of Radiology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA 02215, USA.

出版信息

Clin Cancer Res. 2013 Jul 15;19(14):3936-43. doi: 10.1158/1078-0432.CCR-13-0895. Epub 2013 Jun 6.

Abstract

PURPOSE

Immune-related response criteria (irRC) was developed to adequately assess tumor response to immunotherapy. The irRC are based on bidimensional measurements, as opposed to unidimensional measurements defined by Response Evaluation Criteria in Solid Tumors, which has been widely used in solid tumors. We aimed to compare response assessment by bidimensional versus unidimensional irRC in patients with advanced melanoma treated with ipilimumab.

EXPERIMENTAL DESIGN

Fifty-seven patients with advanced melanoma treated with ipilimumab in a phase II, expanded access trial were studied. Bidimensional tumor measurement records prospectively conducted during the trial were reviewed to generate a second set of measurements using unidimensional, longest diameter measurements. The percent changes of measurements at follow-up, best overall response, and time-to-progression (TTP) were compared between bidimensional and unidimensional irRC. Interobserver variability for bidimensional and unidimensional measurements was assessed in 25 randomly selected patients.

RESULTS

The percent changes at follow-up scans were highly concordant between the 2 criteria (Spearman r: 0.953-0.965, first to fourth follow-up). The best immune-related response was highly concordant between the 2 criteria (κw = 0.881). TTP was similar between the bidimensional and unidimensional assessments (progression-free at 6 months: 70% vs. 81%, respectively). The unidimensional measurements were more reproducible than bidimensional measurements, with the 95% limits of agreement of (-16.1%, 5.8%) versus (-31.3%, 19.7%), respectively.

CONCLUSION

irRC using the unidimensional measurements provided highly concordant response assessment compared with the bidimensional irRC, with less measurement variability. The use of unidimensional irRC is proposed to assess response to immunotherapy in solid tumors, given its simplicity, higher reproducibility, and high concordance with the bidimensional irRC.

摘要

目的

免疫相关缓解标准(irRC)是为了充分评估免疫疗法对肿瘤的疗效而制定的。irRC 基于二维测量,而不是实体瘤反应评估标准中定义的一维测量,后者已广泛用于实体瘤。我们旨在比较使用二维和一维 irRC 评估接受伊匹单抗治疗的晚期黑色素瘤患者的缓解情况。

实验设计

对一项 II 期扩大准入试验中接受伊匹单抗治疗的 57 例晚期黑色素瘤患者进行研究。回顾性地审查试验期间进行的前瞻性二维肿瘤测量记录,使用一维最长直径测量生成第二组测量结果。比较二维和一维 irRC 之间的测量值在随访时的百分比变化、最佳总体缓解和无进展生存期(TTP)。在 25 例随机选择的患者中评估了二维和一维测量的观察者间变异性。

结果

两种标准之间的随访扫描时的百分比变化高度一致(Spearman r:0.953-0.965,首次至第四次随访)。两种标准之间的最佳免疫相关缓解高度一致(κw = 0.881)。TTP 在二维和一维评估之间相似(无进展生存期 6 个月:分别为 70%和 81%)。一维测量比二维测量更具可重复性,其 95%一致性界限分别为(-16.1%,5.8%)和(-31.3%,19.7%)。

结论

与二维 irRC 相比,使用一维测量的 irRC 提供了高度一致的缓解评估,且具有更少的测量变异性。鉴于其简单性、更高的可重复性以及与二维 irRC 的高度一致性,建议在实体瘤中使用一维 irRC 来评估免疫治疗的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b4/3740724/9296ecf01751/nihms-489576-f0001.jpg

相似文献

引用本文的文献

4
Pseudo-hyperprogression of Malignant Pleural Mesothelioma Treated with Nivolumab.纳武单抗治疗恶性胸膜间皮瘤的假性疾病进展
Intern Med. 2025 Aug 1;64(15):2386-2389. doi: 10.2169/internalmedicine.4807-24. Epub 2025 Feb 8.
8
Immunotherapy for advanced and recurrent malignant pleural mesothelioma.恶性胸膜间皮瘤的晚期和复发性免疫治疗。
Cochrane Database Syst Rev. 2024 Sep 18;9(9):CD014720. doi: 10.1002/14651858.CD014720.

本文引用的文献

8
Improved survival with ipilimumab in patients with metastatic melanoma.Ipilimumab 改善转移性黑色素瘤患者的生存。
N Engl J Med. 2010 Aug 19;363(8):711-23. doi: 10.1056/NEJMoa1003466. Epub 2010 Jun 5.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验